American Capital Advisory’s Labcorp LH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.08M Buy
11,001
+61
+0.6% +$16K 1.12% 14
2026
Q1
$2.92M Buy
10,940
+59
+0.5% +$16K 1.18% 12
2025
Q4
$2.73M Sell
10,881
-2,692
-20% -$715K 1.18% 18
2025
Q3
$3.9M Sell
13,573
-402
-3% -$108K 1.81% 10
2025
Q2
$3.67M Sell
13,975
-75
-0.5% -$18.3K 1.84% 11
2025
Q1
$3.27M Sell
14,050
-63
-0.4% -$15.3K 1.76% 10
2024
Q4
$3.24M Sell
14,113
-323
-2% -$74.1K 1.79% 9
2024
Q3
$3.23M Buy
14,436
+9,517
+193% +$2.09M 1.87% 9
2024
Q2
$1.12M Sell
4,919
-26
-0.5% -$5.29K 0.8% 30
2024
Q1
$1.13M Buy
4,945
+26
+0.5% +$5.73K 0.99% 25
2023
Q4
$1.12M Buy
+4,919
New +$1.03M 0.8% 30

Other funds holding LH

American Capital Advisory's LH Position: Q2 2026 in Review

American Capital Advisory increased its Labcorp (LH) stake by 0.56% in Q2 2026, buying an estimated $16K and bringing the position to 11,001 shares worth $3.08M. The position accounts for 1.12% of the portfolio, ranked #14.

American Capital Advisory first reported a position in LH in Q4 2023 and has held it in 11 quarters since. The position peaked at $3.9M in Q3 2025. 1,051 funds tracked by Wall St. Rank hold LH as of Q2 2026.

  • American Capital Advisory held 11,001 shares of Labcorp worth $3.08M as of Q2 2026.
  • American Capital Advisory bought 61 Labcorp shares in Q2 2026, an estimated $16K.
  • Labcorp made up 1.12% of American Capital Advisory's portfolio in Q2 2026, its #14 holding.
  • American Capital Advisory first reported a position in Labcorp in Q4 2023 and has held it in 11 quarters since.
  • American Capital Advisory's Labcorp position peaked at $3.9M in Q3 2025.
  • 1,051 funds tracked by Wall St. Rank held Labcorp as of Q2 2026.

Based on American Capital Advisory's 13F filing for Q2 2026, filed 28 Jul 2026.